At a glance
- Originator Banyu
- Class Anti-ischaemics; Antihypertensives
- Mechanism of Action Endothelin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cerebral vasospasm; Coronary disorders; Hypertension
Most Recent Events
- 14 Sep 2004 Discontinued - Preclinical for Cerebral vasospasm in Japan (unspecified route)
- 14 Sep 2004 Discontinued - Preclinical for Coronary disorders in Japan (unspecified route)
- 14 Sep 2004 Discontinued - Preclinical for Hypertension in Japan (PO)